J0739 HCPCS Level II Code: Injection, cabotegravir, 1mg, FDA approved prescription, only for use as HIV pre-exposure prophylaxis (not for use as treatment for HIV)
Medicare Coverage & Payment
- CMS short descriptor: Hiv prep, inj, cabotegravir
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Pricing indicator: 57
- BETOS: O1E — Other drugs
- Last CMS action effective: January 2, 2025
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- July 1, 2022Added to the code setInjection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
Contextual Map
Every relationship of J0739 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (34)
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg[Sibling]
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg[Sibling]
- J0706 — Injection, caffeine citrate, 5 mg[Sibling]
- J0710 — Injection, cephapirin sodium, up to 1 gm[Sibling]
- J0712 — Injection, ceftaroline fosamil, 10 mg[Sibling]
- J0713 — Injection, ceftazidime, per 500 mg[Sibling]
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g[Sibling]
- and 26 more
Change history
- July 1, 2022 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0739 in its code family, with their registry titles.
- J0725 — Injection, chorionic gonadotropin, per 1,000 usp units
- J0735 — Injection, clonidine hydrochloride, 1 mg
- J0736 — Injection, clindamycin phosphate, 300 mg
- J0737 — Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
- J0738 — Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740 — Injection, cidofovir, 375 mg
- J0741 — Injection, cabotegravir and rilpivirine, 2mg/3mg
- J0742 — Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- J0743 — Injection, cilastatin sodium; imipenem, per 250 mg
- J0744 — Injection, ciprofloxacin for intravenous infusion, 200 mg